标题
Novel approaches to treatingClostridium difficile-associated colitis
作者
关键词
-
出版物
Expert Review of Gastroenterology & Hepatology
Volume 10, Issue 2, Pages 193-204
出版商
Informa UK Limited
发表日期
2015-12-09
DOI
10.1586/17474124.2016.1109444
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Multicenter, Double-Blind, Randomized, Phase 2 Study Evaluating the Novel Antibiotic Cadazolid in Patients with Clostridium difficile Infection
- (2015) Thomas Louie et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mode of Action and Bactericidal Properties of Surotomycin against Growing and Nongrowing Clostridium difficile
- (2015) Mohammed Zahidul Alam et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Prevention of Clostridium difficile Infection With Probiotics
- (2015) Charlesnika T. Evans et al. CLINICAL INFECTIOUS DISEASES
- Investigational new treatments for Clostridium difficile infection
- (2015) Mattias E. Ivarsson et al. DRUG DISCOVERY TODAY
- Tu2054 SYN-004, a Clinical Stage Oral Beta-Lactamase Therapy, Protects the Intestinal Microflora from Antibiotic-Mediated Damage in Humanized Pigs
- (2015) Sheila Connelly et al. GASTROENTEROLOGY
- The Prospect for Vaccines to Prevent Clostridium difficile Infection
- (2015) Chandrabali Ghose et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Diagnosis and Treatment ofClostridium difficilein Adults
- (2015) Natasha Bagdasarian et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Administration of Spores of NontoxigenicClostridium difficileStrain M3 for Prevention of RecurrentC difficileInfection
- (2015) Dale N. Gerding et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Burden of Clostridium difficile Infection in the United States
- (2015) Fernanda C. Lessa et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clostridium difficile Infection
- (2015) Daniel A. Leffler et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mo1116 The Efficacy and Safety of Rifaximin vs. Vancomycin in the Treatment of Mild to Moderate C. difficile Infection: A Randomized Double-Blind Active Comparator Trial
- (2015) Darrell S. Pardi et al. GASTROENTEROLOGY
- The Evolution of Urban C. difficile Infection (CDI): CDI in 2009–2011 Is Less Severe and has Better Outcomes Than CDI in 2006–2008
- (2014) Paul Feuerstadt et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Fidaxomicin Inhibits Clostridium difficile Toxin A-Mediated Enteritis in the Mouse Ileum
- (2014) Hon Wai Koon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cost-effectiveness of Competing Strategies for Management of Recurrent Clostridium difficile Infection: A Decision Analysis
- (2014) Gauree G. Konijeti et al. CLINICAL INFECTIOUS DISEASES
- Vancomycin, Metronidazole, or Tolevamer for Clostridium difficile Infection: Results From Two Multinational, Randomized, Controlled Trials
- (2014) Stuart Johnson et al. CLINICAL INFECTIOUS DISEASES
- Hospital-Acquired Clostridium difficile Infections
- (2014) Eric T. Lofgren et al. EPIDEMIOLOGY
- Targeted adsorption of molecules in the colon with the novel adsorbent-based Medicinal Product, DAV132: A proof of concept study in healthy subjects
- (2014) Jean de Gunzburg et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Multistate Point-Prevalence Survey of Health Care–Associated Infections
- (2014) Shelley S. Magill et al. NEW ENGLAND JOURNAL OF MEDICINE
- Commercially available probiotic drinks containingLactobacillus caseiDN-114001 reduce antibiotic-associated diarrhea
- (2014) Christoph G Dietrich WORLD JOURNAL OF GASTROENTEROLOGY
- Guidelines for Diagnosis, Treatment and Prevention of Clostridium difficile Infections
- (2013) Christina M Surawicz et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Investigations of the Mode of Action and Resistance Development of Cadazolid, a New Antibiotic for Treatment of Clostridium difficile Infections
- (2013) Hans H. Locher et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Human Monoclonal Antibodies against Clostridium difficile Toxins A and B Inhibit Inflammatory and Histologic Responses to the Toxins in Human Colon and Peripheral Blood Monocytes
- (2013) Hon Wai Koon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroandIn VivoAntibacterial Evaluation of Cadazolid, a New Antibiotic for Treatment of Clostridium difficile Infections
- (2013) Hans H. Locher et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Is Fidaxomicin Worth the Cost? An Economic Analysis
- (2013) Sarah M. Bartsch et al. CLINICAL INFECTIOUS DISEASES
- The Epidemiology of Clostridium difficile Infection in Children: A Population-Based Study
- (2013) Sahil Khanna et al. CLINICAL INFECTIOUS DISEASES
- European Society of Clinical Microbiology and Infectious Diseases: Update of the Treatment Guidance Document for Clostridium difficile Infection
- (2013) S.B. Debast et al. CLINICAL MICROBIOLOGY AND INFECTION
- Investigating the candidacy of a lipoteichoic acid-based glycoconjugate as a vaccine to combat Clostridium difficile infection
- (2013) Andrew D. Cox et al. GLYCOCONJUGATE JOURNAL
- Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
- (2013) Els van Nood et al. NEW ENGLAND JOURNAL OF MEDICINE
- Horizontal gene transfer converts non-toxigenic Clostridium difficile strains into toxin producers
- (2013) Michael S.M. Brouwer et al. Nature Communications
- Clostridium difficile infection in the twenty-first century
- (2013) Chandrabali Ghose Emerging Microbes & Infections
- Clostridium difficile infection: management strategies for a difficult disease
- (2013) Sahil Khanna et al. Therapeutic Advances in Gastroenterology
- Standardized Frozen Preparation for Transplantation of Fecal Microbiota for Recurrent Clostridium difficile Infection
- (2012) Matthew J Hamilton et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- In VitroandIn VivoCharacterization of CB-183,315, a Novel Lipopeptide Antibiotic for Treatment of Clostridium difficile
- (2012) Carmela T. M. Mascio et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of an Oral Suspension of VP20621, Spores of Nontoxigenic Clostridium difficile Strain M3, in Healthy Subjects
- (2012) Stephen A. Villano et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Can we identify patients at high risk of recurrent Clostridium difficile infection?
- (2012) C.P. Kelly CLINICAL MICROBIOLOGY AND INFECTION
- Treating recurrent C. difficile infection—the challenge continues
- (2012) Christina M. Surawicz Nature Reviews Gastroenterology & Hepatology
- Clostridium difficile: Development of a novel candidate vaccine
- (2012) Ginamarie Foglia et al. VACCINE
- Diverting Loop Ileostomy and Colonic Lavage
- (2011) Matthew D. Neal et al. ANNALS OF SURGERY
- Systematic Review of Intestinal Microbiota Transplantation (Fecal Bacteriotherapy) for Recurrent Clostridium difficile Infection
- (2011) Ethan Gough et al. CLINICAL INFECTIOUS DISEASES
- Comparison of the Burdens of Hospital-Onset, Healthcare Facility-Associated Clostridium difficile Infection and of Healthcare-Associated Infection due to Methicillin-Resistant Staphylococcus aureus in Community Hospitals
- (2011) Becky A. Miller et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Fidaxomicin versus Vancomycin forClostridium difficileInfection
- (2011) Thomas J. Louie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders
- (2011) Theodoros Kelesidis et al. Therapeutic Advances in Gastroenterology
- Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)
- (2010) Stuart H. Cohen et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Clostridium difficile PCR ribotype 027: assessing the risks of further worldwide spread
- (2010) Archie CA Clements et al. LANCET INFECTIOUS DISEASES
- A new macrocyclic antibiotic, fidaxomicin (OPT-80), causes less alteration to the bowel microbiota of Clostridium difficile-infected patients than does vancomycin
- (2010) G. W. Tannock et al. MICROBIOLOGY-SGM
- Treatment with Monoclonal Antibodies againstClostridium difficileToxins
- (2010) Israel Lowy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Review article: anti-inflammatory mechanisms of action ofSaccharomyces boulardii
- (2009) C. POTHOULAKIS ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Nitazoxanide versus Vancomycin inClostridium difficileInfection: A Randomized, Double‐Blind Study
- (2009) Daniel M. Musher et al. CLINICAL INFECTIOUS DISEASES
- Treatment of Clostridium difficile-Associated Disease
- (2009) Daniel A. Leffler et al. GASTROENTEROLOGY
- Comparative Efficacies of Rifaximin and Vancomycin for Treatment of Clostridium difficile-Associated Diarrhea and Prevention of Disease Recurrence in Hamsters
- (2008) E. Kokkotou et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- OPT-80, a macrocyclic antimicrobial agent for the treatment ofClostridium difficileinfections: a review
- (2008) Michael Gerber et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Prospective Derivation and Validation of a Clinical Prediction Rule for Recurrent Clostridium difficile Infection
- (2008) Mary Y. Hu et al. GASTROENTEROLOGY
- Meta-analysis to assess risk factors for recurrent Clostridium difficile infection
- (2008) K.W. Garey et al. JOURNAL OF HOSPITAL INFECTION
- Clostridium difficile— More Difficult Than Ever
- (2008) Ciarán P. Kelly et al. NEW ENGLAND JOURNAL OF MEDICINE
- INCREASE IN CLOSTRIDIUM DIFFICILE-RELATED HOSPITALIZATIONS AMONG INFANTS IN THE UNITED STATES, 2000–2005
- (2008) Marya D. Zilberberg et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started